Loss of CD4+ T cell proliferative ability but not loss of human immunodeficiency virus type 1 specificity equates with progression to disease

被引:103
作者
Wilson, JDK
Imami, N
Watkins, A
Gill, J
Hay, P
Gazzard, B
Westby, M
Gotch, FM
机构
[1] Chelsea & Westminster Hosp, Imperial Coll Sch Med Chelsea & Westminster, Dept Immunol, London SW10 9NH, England
[2] Chelsea & Westminster Hosp, Imperial Coll Sch Med Chelsea & Westminster, Dept HIV Genitourinary Med, London SW10 9NH, England
[3] Roche Discovery, Welwyn Garden City, Herts, England
[4] St George Hosp, Dept Genitourinary Med, Tooting, England
基金
英国惠康基金;
关键词
D O I
10.1086/315764
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
In this study, we compared human immunodeficiency virus (HIV) type 1-specific proliferative responses with HIV-1-induced intracellular cytokine production in a cohort of clinically nonprogressing patients and individuals with progressive HIV-1 infection. We found strong HIV-1-specific proliferative responses in the clinical nonprogressor cohort that correlated with significant numbers of circulating HIV-1-specific CD4(+) T cells. In contrast, HIV-1-specific proliferative responses were absent in most individuals with progressive HIV-1 infection, even though interferon-gamma-producing HIV-1-specific CD4(+) T cells were detectable by flow cytometry. The implication of these data is that the important dysfunction seen in most HIV-positive patients from very early in disease may be an inability of HIV-1-specific CD4(+) memory T cells to proliferate in response to HIV antigens rather than an absolute loss of circulating virus-specific CD4(+) T cells.
引用
收藏
页码:792 / 798
页数:7
相关论文
共 29 条
  • [11] Imami N, 1999, CLIN EXP IMMUNOL, V118, P78
  • [12] INHIBITION OF ALLOREACTIVITY BY MAB MR6 - DIFFERENTIAL-EFFECTS ON IL-2-PRODUCING AND IL-4-PRODUCING HUMAN T-CELLS
    IMAMI, N
    LARCHE, M
    RITTER, MA
    [J]. INTERNATIONAL IMMUNOLOGY, 1994, 6 (10) : 1575 - 1584
  • [13] JACOB CO, 1992, SEMIN IMMUNOL, V3, P147
  • [14] Alterations in the immune response of human immunodeficiency virus (HIV)-infected subjects treated with an HIV-specific protease inhibitor, ritonavir
    Kelleher, AD
    Carr, A
    Zaunders, J
    Cooper, DA
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1996, 173 (02) : 321 - 329
  • [15] LYMPHOCYTE PROLIFERATIVE RESPONSES TO HUMAN IMMUNODEFICIENCY VIRUS-ANTIGENS INVITRO
    KROWKA, JF
    STITES, DP
    JAIN, S
    STEIMER, KS
    GEORGENASCIMENTO, C
    GYENES, A
    BARR, PJ
    HOLLANDER, H
    MOSS, AR
    HOMSY, JM
    LEVY, JA
    ABRAMS, DI
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1989, 83 (04) : 1198 - 1203
  • [16] PATHOGENESIS OF HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION
    LEVY, JA
    [J]. MICROBIOLOGICAL REVIEWS, 1993, 57 (01) : 183 - 289
  • [17] ABILITY OF HIV TO PROMOTE A T(H)1 TO T(H)0 SHIFT AND TO REPLICATE PREFERENTIALLY IN T(H)2 AND T(H)0 CELLS
    MAGGI, E
    MAZZETTI, M
    RAVINA, A
    ANNUNZIATO, F
    DECARLI, M
    PICCINNI, MP
    MANETTI, R
    CARBONARI, M
    PESCE, AM
    DELPRETE, G
    ROMAGNANI, S
    [J]. SCIENCE, 1994, 265 (5169) : 244 - 248
  • [18] CD4(+) T-CELLS ARE REQUIRED TO SUSTAIN CD8(+) CYTOTOXIC T-CELL RESPONSES DURING CHRONIC VIRAL-INFECTION
    MATLOUBIAN, M
    CONCEPCION, RJ
    AHMED, R
    [J]. JOURNAL OF VIROLOGY, 1994, 68 (12) : 8056 - 8063
  • [19] PLEIOTROPY AND REDUNDANCY - T-CELL-DERIVED LYMPHOKINES IN THE IMMUNE-RESPONSE
    PAUL, WE
    [J]. CELL, 1989, 57 (04) : 521 - 524
  • [20] HIV-1-specific CD4+ T cells are detectable in most individuals with active HIV-1 infection, but decline with prolonged viral suppression
    Pitcher, CJ
    Quittner, C
    Peterson, DM
    Connors, M
    Koup, RA
    Maino, VC
    Picker, LJ
    [J]. NATURE MEDICINE, 1999, 5 (05) : 518 - 525